Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease
- PMID: 24256244
- DOI: 10.1042/BST20130194
Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease
Abstract
iPSCs (induced pluripotent stem cells) are the newest tool used to model PD (Parkinson's disease). Fibroblasts from patients carrying pathogenic mutations that lead to PD have been reprogrammed into iPSCs, which can subsequently be differentiated into important cell types. Given the characteristic loss of dopaminergic neurons in the substantia nigra pars compacta of PD patients, iPSC-derived midbrain dopaminergic neurons have been generated to investigate pathogenic mechanisms in this important cell type as a means of modelling PD. iPSC-derived cultures studied so far have been made from patients carrying mutations in LRRK2 (leucine-rich repeat kinase 2), PINK1 [PTEN (phosphatase and tensin homologue deleted on chromosome 10)-induced putative kinase 1], PARK2 (encodes parkin) or GBA (β-glucocerebrosidase), in addition to those with SNCA (α-synuclein) multiplication and idiopathic PD. In some cases, isogenic control lines have been created to minimize inherent variability between lines from different individuals. Disruptions in autophagy, mitochondrial function and dopamine biology at the synapse have been described. Future applications for iPSC-derived models of PD beyond modelling include drug testing and the ability to investigate the genetic diversity of PD.
Similar articles
-
Cellular reprogramming: a new approach to modelling Parkinson's disease.Biochem Soc Trans. 2012 Oct;40(5):1152-7. doi: 10.1042/BST20120159. Biochem Soc Trans. 2012. PMID: 22988881 Review.
-
Parkinson's disease in a dish - Using stem cells as a molecular tool.Neuropharmacology. 2014 Jan;76 Pt A:88-96. doi: 10.1016/j.neuropharm.2013.08.035. Epub 2013 Sep 10. Neuropharmacology. 2014. PMID: 24035919 Review.
-
Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.J Parkinsons Dis. 2018;8(4):479-493. doi: 10.3233/JPD-181353. J Parkinsons Dis. 2018. PMID: 30149462 Free PMC article. Review.
-
Modeling Parkinson's disease using induced pluripotent stem cells.Curr Neurol Neurosci Rep. 2012 Jun;12(3):237-42. doi: 10.1007/s11910-012-0270-y. Curr Neurol Neurosci Rep. 2012. PMID: 22538490 Free PMC article. Review.
-
Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.PLoS One. 2016 May 18;11(5):e0154890. doi: 10.1371/journal.pone.0154890. eCollection 2016. PLoS One. 2016. PMID: 27191603 Free PMC article.
Cited by
-
Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases.Stem Cells Int. 2015;2015:382530. doi: 10.1155/2015/382530. Epub 2015 Jul 9. Stem Cells Int. 2015. PMID: 26240571 Free PMC article. Review.
-
Energy Metabolism and Intracellular pH Alteration in Neural Spheroids Carrying Down Syndrome.Biomedicines. 2021 Nov 22;9(11):1741. doi: 10.3390/biomedicines9111741. Biomedicines. 2021. PMID: 34829971 Free PMC article.
-
Stem cell transplantation therapy in Parkinson's disease.Springerplus. 2015 Oct 13;4:597. doi: 10.1186/s40064-015-1400-1. eCollection 2015. Springerplus. 2015. PMID: 26543732 Free PMC article. Review.
-
Large-scale generation of human iPSC-derived neural stem cells/early neural progenitor cells and their neuronal differentiation.Organogenesis. 2014;10(4):365-77. doi: 10.1080/15476278.2015.1011921. Organogenesis. 2014. PMID: 25629202 Free PMC article.
-
Growth-factor reduced Matrigel source influences stem cell derived brain microvascular endothelial cell barrier properties.Fluids Barriers CNS. 2016 Apr 12;13:6. doi: 10.1186/s12987-016-0030-5. Fluids Barriers CNS. 2016. PMID: 27068644 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
